Companies that use Agiloft

Source: Analysis of 100 job postings that mention Agiloft

My analysis shows that Agiloft purchasing decisions cluster heavily in three departments: Contract Management (17%), Procurement and Sourcing (13%), and IT leadership (11%). These buyers are hiring for transformation roles focused on modernizing legal operations and procurement systems. They prioritize automation, scalability, and cost reduction. Associate Directors in Contract Management Solutions (9%) represent a specialized technical buyer persona bridging business and IT needs.

Day-to-day users span a wider range than buyers. Contract Specialists (10%) handle the operational work of drafting, reviewing, and managing agreements. I noticed significant demand for roles that combine legal operations with technical skills, like Legal Engineers and CLM Implementation Managers who configure workflows, manage integrations with systems like Workday and SAP, and drive adoption. The postings emphasize document control, vendor management, and spend analytics as core daily activities.

The pain points reveal urgent needs around process efficiency and scale. Companies describe wanting to "streamline and adhere to coding standards" and "drive greater insight, analytics, and efficiencies for a global organization." Multiple postings mention "touchless P2P" and "automation" goals. One role explicitly seeks to "optimize spend, maximize relationships, minimize risk" while another emphasizes "sustainable value" through better contract governance. The recurring theme is transforming contract management from administrative overhead into strategic advantage through better technology and data visibility.

Source: Analysis of tech stacks from 648 companies that use Agiloft

I noticed that companies using Agiloft are primarily enterprise organizations in highly regulated industries, particularly life sciences, healthcare, and pharmaceuticals. The overwhelming presence of tools like Veeva Vault and Medidata Rave, which are specialized platforms for clinical trials and pharmaceutical operations, tells me these aren't typical B2B SaaS companies. These are organizations dealing with complex compliance requirements, extensive documentation needs, and rigorous audit trails.

The pairing of Agiloft with Navex One and Proofpoint Security Training makes perfect sense for this profile. When you're running clinical trials or managing pharmaceutical operations, governance, risk, and compliance become central to everything you do. These companies need robust contract lifecycle management from Agiloft to handle complex supplier agreements, clinical trial contracts, and vendor relationships, while Navex One manages their ethics and compliance training. The Veeva Vault connection is particularly telling because it's the gold standard for life sciences document management, suggesting Agiloft handles the contract and agreement side while Veeva manages regulatory submissions and quality documentation.

The full stack reveals mature, process-driven organizations that are definitely not product-led. These are traditional enterprise companies with complex procurement processes, long sales cycles, and multiple stakeholders involved in every decision. The presence of ServiceNow alongside Agiloft suggests sophisticated IT operations with formal ticketing and workflow automation. Qualtrics indicates they're measuring customer experience and employee engagement systematically, which points to established companies with resources dedicated to continuous improvement rather than scrappy startups focused purely on growth.

Source: Analysis of Linkedin bios of 648 companies that use Agiloft

I noticed that Agiloft's customers span an impressive range of industries, but they share a common thread: complexity. These aren't simple businesses. They're organizations operating sophisticated operations like biotechnology research companies developing CRISPR therapies and immunotherapies, major healthcare systems managing thousands of employees across multiple facilities, engineering firms handling intricate construction projects, and financial institutions navigating regulatory requirements. Many are in highly regulated sectors including pharmaceuticals, healthcare, financial services, and government where compliance and documentation are critical.

These are predominantly mature, established organizations. The employee counts tell the story: I saw numerous companies with 1,000 to 10,000+ employees, multi-billion dollar revenues, and decades of operating history. Many are publicly traded or have significant institutional backing. Even the smaller biotechnology companies in the 50-200 employee range are well-funded clinical or post-IPO stage firms, not early startups.